Evi Hatziandreou (MD, DrPH), Dr. of Public Health, University of Harvard, Vice President of FairLife LCC
Kyriakos Souliotis, Professor of Health Policy, Dean of the Faculty of Social and Political Sciences, University of Peloponnese
Helena Linardou (MD, PhD), Medical Oncologist, Director of the 4th Oncology Clinic – Metropolitan Hospital, President of the Scientific Committee of HeCOG (HeLLENIC COΟPERATIVE ONCOLOGY GROUP)

Commentary discusion

Eirini Agapidaki, General Secretary, Ministry of Health
Stelios Loukidis (MD, FCCP, FERS), Professor of Respiratory Medicine, National and Kapodistrian University of Athens, President of the Hellenic Thoracic Society (HTS)

Comprehensive genomic profiling (CGP) – New technologies in molecular identification of tumors (challenges – best practices)
Petros Christopoulos (MD, PhD) (11:30-11:45)
Medical Oncologist & Hematologist
Professor of Pathological Oncology, Heidelberg University

Liquid biopsy: clinical applications (present and future) – The role of repeat biopsy
Evi Lianidou (PhD) (11:45-12:00)
Professor of Analytical Chemistry – Clinical Chemistry Department of Chemistry, National and Kapodistrian University of Athens

Adoption, reimbursement status, challenges and prospects
Theofanis Rigatos (12:00-12:15)
Head of the Independent Directorate of Contracts and Vendor Auditing, National Organization for Health Care Services Provision (EOPPY)

Commentary discussion:

12:15 – 12:35

Zenia Saridaki (MD, PhD), Medical Oncologist, President of the Hellenic Society of Medical Oncology (HeSMO)
Aphrodite Nonni (MD), Pathologist, President of the Hellenic Society of Pathology (HSP)
Kathi Apostolidis,President Hellinic Cancer Federation – ELLOK – ECPC Past President – Chair Scientific Committee.

ALK
Athina Christopoulou (MD, Ph.D) (12:50-13:00)
Medical Oncologist, Director of Oncology Unit, General Hospital of Patra

EGFR – EXON20
George Lainakis (MD) (13:00-13:10)
Medical Oncologist, Deputy Head of the 4th Oncology Department, Metropolitan Hospital

KRAS
Ferdinandos Skoulidis (MD, PhD, MRCP) (13:10-13:20)
Head and Neck Medical Oncology Division Cancer Medicineut MD Anderson Cancer Center, Department Of Thoracic-Head & Neck Med Onc

BRAF , HER2 , MET
Michalis Liontos (MD, PhD) (13:20-13:30)
Medical Oncologist, Assistant Professor at the Department of Clinical Therapeutics, Oncology Unit, Alexandra Hospital, National and Kapodistrian University of Athens

ROS 1 , RET , NTRK
Maria Skondra (MD) (13:30-13:40)
Medical Oncologist Registrar, 3rd Internal Medicine-Oncology Clinic, Henry Dunant Hospital

TILs, Tumor Infiltrating Lymphocytes στον NSC Lung Cancer; delivering the therapy at the Point of Care.
Evi Hatziandreou (MD, DrPH) (13:40-13:50)
Sr. Director, Health Policy and Market Access. Theracell Advanced Biotechnology, Vice President of FairLife LCC

Commentary discussion:

13:50-14:15 

Paraskevi Katsaounou (MD), Pulmonologist, Associate Professor of Pulmonary Medicine, School of Medicine, National and Kapodistrian University of Athens
Anna Batistatou (MD, PhD),Professor of Pathology, Director of the Department of Pathology UOI and of the Pathology/Cytology Laboratory UHI, University of Ioannina, Greece
Ioannis Boukovinas (MD, PhD, PharmaD), Medical Oncologist, Scientific Manager of Medical Oncology Unit at Bioclinic Thessaloniki
Epaminondas Samantas (MD, PhD), Medical Oncologist, Director of the 2nd Oncology Department, Metropolitan Hospital

The role of immunotherapy in early-stage NSCLC
Ioannis Mountzios (MD, MSc, PhD) (14:50-15:05)
Medical Oncologist, Director 4th Oncology Department and Clinical Trials Unit, Henry Dunant Hospital Center

The contribution of immunotherapy to metastatic NSCLC
Ilias Athanasiadis (MD) (15:05-15:20)
Medical Oncologist, Director of the Oncology Clinic, Mitera Hospital

Digital applications for cancer: National Registry, Treatment Protocols, Oncological File
Panagiota Mitrou (15:20-15:35)
Head of Independent Department of Therapeutic Protocols and Patient Registries
Ministry of Health

Patient view – Lived experience
Christos Apostolakos (15:35-15:40)

Commentary discussion:

15:40-16:10 

Dimitra Kanaloupiti (MD), Medical Oncologist, Director of the 4th Oncology Clinic, Iaso Hospital
Paris Kosmidis (MD), Medical Oncologist, Director of the 2nd Internal Medicine-Oncology Clinic, Ygeia Hospital
Anastasios Boutis (MD), Medical Oncologist, Theagenio Cancer Hospital, Thessaloniki, General Secretary of HeSMO
Zoi Grammatoglou, President of the KEFI Association (Association of Cancer Patients, Volunteers, Friends and Doctors of Athens)

Clinical studies, present and future
Helena Linardou (MD, PhD) (16:15-16:30)
Medical Oncologist, Director of the 4th Oncology Clinic – Metropolitan Hospital, President of the Scientific Committee of HeCOG

Academic research facts
Amanda Psyrri (MD, PhD, FACP) (16:30-16:45)
Professor of internal medicine and medical oncology
Chairman,2nd Department of internal medicine
ATTIKON university hospital

Regulatory framework, challenges and prospects
Dimitris Philippou (16:45-17:00)
General Surgeon, Assistant Professor of Anatomy, National & Kapodistrian University of Athens,
President of the National Organization for Medicines (EOF)

Lived experience
George Siaravas (17:00-17:05)
Patient advocate, Ambassador ICAN

Patients Advocacy (17:05-17:20)
Janet Freeman Daily, Co-Founder President, Board Chair – The ROS1ders, Inc
Terri Conneran, Founder of KRASKickers
Lindi Campbell, President Breath of Hope KY, Inc.

The role of pharmaceutical industry

Roche Hellas
Konstantinos Poulimenos
Head of the Clinical Trial Operations Department

AstraZeneca Greece
Christos Antonopoulos (MD, PhD, EMBA) 
Director of the Oncology-Hematology Business Unit

Amgen
Periklis Giovas (MD, PhD)
Medical Director

BMS Greece
Zefi Vlachopioti
Market Access Lead

Janssen
Dimitris Stathopoulos (MD, MSc, PhD)
Therapeutic Area Lead Oncology/Hematology/PAH

Commentary discussion:

17:50 – 18:15

Nikos Dedes, President of the Greek Patient Association 
Kyriakos Souliotis, Professor of Health Policy, Dean of the Faculty of Social and Political Sciences, University of Peloponnese
Caius Kim, Global Director,AstraZeneca,Lung Ambition Alliance
Andrew Ciupek (PhD) Associate Director, Clinical Research GO2 Foundation
Amy Moore (PhD) VP, Global Engagement and Patient Partnerships LUNGevity Foundation